Please login to the form below

Not currently logged in
Email:
Password:

data transparency

This page shows the latest data transparency news and features for those working in and with pharma, biotech and healthcare.

Audit exposes gaps in pharma's promises on trial transparency

Audit exposes gaps in pharma's promises on trial transparency

transparency, followed by LEO Pharma, Takeda, Pfizer, Novartis, Novo Nordisk, Boehringer Ingelheim, Amgen, Merck &Co and AbbVie. ... CSRs) and individual patient data (IPD) - and gauges how well they meet a reference standard.

Latest news

  • US scientists still wary of Gottlieb's industry ties US scientists still wary of Gottlieb's industry ties

    Among other key findings were that the majority of participants agreed that the FDA should work on data transparency - including releasing information on both approved and denied drugs - while more than

  • Nearly half of all clinical trials not published Nearly half of all clinical trials not published

    Commenting on the research, director general of European pharma body EFPIA, Richard Bergström said: “ On the journey towards clinical data transparency, EFPIA and its members are ready to be held to ... EFPIA supports the intent of the new EU Clinical

  • Daiichi Sankyo begins sharing clinical trial data online Daiichi Sankyo begins sharing clinical trial data online

    Daiichi Sankyo has joined many of its industry peers in their transparency efforts by signing up to a portal that provides anonymised patient-level data on request to qualified researchers. ... Since May 2013 the AllTrials transparency campaign says data

  • Harnessing clinical data Harnessing clinical data

    Investigator registry. Paediatric trial efficiencies. Clinical trial diversification. Clinical data transparency. ... Quality management systems. Electronic labels. Placebo and standard of care data sharing/li>.

  • Just manufacturing pills ‘no longer good enough for patients’ Just manufacturing pills ‘no longer good enough for patients’

    Big data and consent. Data transparency was also a key issue at the event. ... Griffiths echoed the need for transparency. In a panel debate, she said: “ People share data all time - but we have to gain consent.”.

More from news
Approximately 19 fully matching, plus 70 partially matching documents found.

Latest Intelligence

  • Exploring serious market access roadblocks for rare bleeding disorders Exploring serious market access roadblocks for rare bleeding disorders

    Healthcare policymakers and advocacy groups need to have consistent and structured patient data. ... One source points out how transparency of individual patient data is essential to personalise treatments and improve patient health, as it allows

  • LEO: Patients benefit from transparency LEO: Patients benefit from transparency

    We have a scientific and ethnical responsibility to make clinical trial data available because of this.”. ... LEO Pharma announced its commitments to trial transparency back in 2013, following a workshop on clinical trial data and transparency

  • The Heart of the Matter 9: Context is king The Heart of the Matter 9: Context is king

    The transparency agenda has spawned an ever-increasing expansion of the ʻgrey literatureʼ. ... As the combination of digital innovation and data transparency transforms stakeholder engagement, companies are increasingly seeking new ways to cut through

  • The Heart of the Matter 9: Context is king The Heart of the Matter 9: Context is king

    The transparency agenda has spawned an ever-increasing expansion of the ʻgrey literatureʼ. ... As the combination of digital innovation and data transparency transforms stakeholder engagement, companies are increasingly seeking new ways to cut through

  • Business as usual Business as usual

    2016. She highlighted two areas of particular interest covered by the Code: collecting transparency data and examining the details of international meetings. ... Beryl also highlighted the need for transparency in reports produced after such events.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Sanofi CEO Viehbacher to head EFPIA Sanofi CEO Viehbacher to head EFPIA

    One of the most pressing matters for EFPIA is the seemingly inevitable trend towards transparency of trial data, and Viehbacher has already commented on the subject.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics